A61P 5/30
Oestrogens
A61P5/30 (Oestrogens) appears on 713 US grants and 1,083 published applications in this corpus.
Search patents in A61P- Granted patents
- 713
- Published applications
- 1,083
- Assignees
- 434
- Inventors
- 1,925
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 10 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 16 | 0 |
| 2000 | 24 | 0 |
| 2001 | 25 | 16 |
| 2002 | 27 | 32 |
| 2003 | 26 | 80 |
| 2004 | 32 | 93 |
| 2005 | 22 | 90 |
| 2006 | 35 | 66 |
| 2007 | 28 | 81 |
| 2008 | 39 | 67 |
| 2009 | 28 | 66 |
| 2010 | 48 | 75 |
| 2011 | 38 | 57 |
| 2012 | 37 | 56 |
| 2013 | 28 | 41 |
| 2014 | 36 | 35 |
| 2015 | 36 | 35 |
| 2016 | 29 | 38 |
| 2017 | 29 | 25 |
| 2018 | 25 | 19 |
| 2019 | 11 | 25 |
| 2020 | 17 | 22 |
| 2021 | 16 | 17 |
| 2022 | 12 | 5 |
| 2023 | 10 | 19 |
| 2024 | 5 | 10 |
| 2025 | 3 | 6 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-surgical prevention of boar taint and aggressive behavior4 Aug 2026US 12,697,342 B2Insigna Inc.
- Compounds and their uses for alleviating menopause-associated symptoms4 Nov 2025US 12,458,651 B2Estetra Srl
- Compounds and their uses for alleviating menopause-associated symptoms19 Aug 2025US 12,390,478 B2Estetra Srl
- Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof25 Feb 2025US 12,233,052 B2Genentech, Inc.
- Orodispersible formulations31 Dec 2024US 12,178,824 B2Millicent Pharma Limited
- Glucuronidase activator, pharmaceutical composition, edible composition, and oral composition10 Sep 2026US 2026/0263540 A1Kaneka Corporation
- Methods and devices for hormone replacement therapy30 Jul 2026US 2026/0216062 A1
- Use of estetrol in hepatically impaired patients23 Jul 2026US 2026/0207623 A1Estetra Srl
- Estrogen receptor modulators and uses thereof16 Apr 2026US 2026/0103461 A1Olema Pharmaceuticals, Inc.
- Compositions for non-surgical prevention of boar taint and aggressive behavior19 Mar 2026US 2026/0076978 A1Insigna Inc.
Most cited
By later US patents
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001
- Solubility parameter based drug delivery system and method for altering drug saturation concentration234US 5,474,783 ANoven Pharmaceuticals, Inc. · 1995
- Solubility parameter based drug delivery system and method for altering drug saturation concentration219US 5,958,446 ANoven Pharmaceuticals, Inc. · 1999
- Transdermal therapeutic system containing estradiol153US 6,521,250 B2LTS Lohmann Therapie-Systeme AG · 2003
- Methods and compositions for treating and preventing symptoms of hormonal variations135US 8,461,102 B22013